Purchase Order 36C24226P0910
Award Date 8/20/26
Potential Completion Date 8/21/26
Potential Value $39K
Federal Agency
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Northport, NY 11768, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Veterans Integrated Service Network 5 awarded a purchase order to Theracom, L.L.C. for TAKHZYRO 150 MG with a ceiling value of $38,097.52 on April 14, 2026, with completion by April 17, 2026. The order carries no set-aside designation. Place of performance is Brooks, Kentucky. This firm fixed-price purchase order procures the specialized biologic pharmaceutical TAKHZYRO (lanadelumab) for the Department of Veterans Affairs healthcare system. Theracom is a pharmaceutical supply vendor and a...
- <p>The Veterans Integrated Service Network 2 awarded a purchase order to Theracom, L.L.C. for $38,875.02 on May 20, 2026, with completion by May 27, 2026. The order is for TAKHZYRO 150MG/ML injection in 2ML syringe formulation. Performance occurs at Brooks, Kentucky. No set-aside was used. Theracom is a child entity of Cencora, Inc. (Amerisourcebergen) and specializes in supplying specialized pharmaceutical therapies to federal healthcare systems.</p>
- The Department of Veterans Affairs, Veterans Integrated Service Network 2 (VISN 2) awarded a $38,875.02 firm fixed-price purchase order to Theracom, L.L.C. on March 18, 2026 for the supply of TAKHZYRO 150MG/ML injection in 2ML syringe formulation. The contract, which will be completed by March 25, 2026, was awarded without a set-aside designation and will be performed at Theracom's location in Brooks, Kentucky. Theracom is a specialty pharmaceutical distributor headquartered in Shepherdsville,...
- The Department of Veterans Affairs, Veterans Integrated Service Network 2 (VISN 2) awarded a firm fixed-price purchase order to Theracom, L.L.C. for TAKHZYRO 150MG/ML injection in 2ML syringe formulation on February 24, 2026. The contract has a ceiling value of $38,875.02 with an ultimate completion date of March 24, 2026. The award was made without a set-aside designation, reflecting full and open competition. Theracom, a Kentucky-based pharmaceutical specialty distributor headquartered in...
- Theracom, L.L.C., a Kentucky-based specialty pharmaceutical supplier, has been awarded a firm fixed-price purchase order valued at $38,875.02 by Veterans Integrated Service Network 2 (VISN 2) of the Department of Veterans Affairs for the supply of TAKHZYRO 150MG/ML injection in 2ML syringe formulation. The contract was awarded on April 15, 2026, with an ultimate completion date of April 21, 2026, and carries no set-aside designation. Performance will be executed at Theracom's location in Brooks,...
- Veterans Integrated Service Network 5 (VISN 5) of the Department of Veterans Affairs awarded a purchase order to Theracom, L.L.C. for TAKHZYRO 150 mg with a ceiling value of $38,097.52 on June 22, 2026, with ultimate completion by June 24, 2026. No set-aside was used. Performance occurs at Brooks, Kentucky. Theracom, a pharmaceutical supply specialist headquartered in Kentucky and a child entity of Cencora, Inc., supplies specialized biologic medications to federal healthcare systems. The firm...
- The Department of Veterans Affairs, Veterans Integrated Service Network 5 (VISN 5) awarded a firm fixed-price purchase order to Theracom, L.L.C. on April 27, 2026, for the supply of TAKHZYRO 150 MG, a specialized biologic pharmaceutical therapy. The contract carries a ceiling value of $38,097.52 with an ultimate completion date of April 30, 2026, and was awarded without set-aside designation on a full and open competitive basis. Theracom, a Kentucky-based pharmaceutical supply company...
- <p>The Department of Veterans Affairs, Veterans Integrated Service Network 5, awarded a purchase order to Theracom, L.L.C. for TAKHZYRO 150 MG with a ceiling value of $38,097.52 on May 19, 2026, with completion by May 20, 2026. No set-aside was used. Performance occurs at Brooks, Kentucky. The order is firm fixed-price for the supply of this specialized pharmaceutical therapy to the federal healthcare system.</p>
- <p>The Department of Veterans Affairs, Veterans Integrated Service Network 5, awarded a purchase order to Theracom, L.L.C. for TAKHZYRO 150 MG with a ceiling value of $38,097.52 on July 2, 2026, with completion by July 7, 2026. No set-aside was used. Performance occurs at Brooks, Kentucky. The order is for supply of the specialized pharmaceutical therapy TAKHZYRO (lanadelumab) as a firm fixed-price commercial purchase.</p>
- The Department of Veterans Affairs, Veterans Integrated Service Network 5 (VISN 5) awarded a firm fixed-price purchase order to Theracom, L.L.C. for $38,097.52 for the supply of TAKHZYRO 150 MG, a specialized biologic pharmaceutical therapy. The contract was awarded on March 2, 2026, with an ultimate completion date of March 4, 2026, and no set-aside designation was utilized. Theracom, headquartered in Shepherdsville, Kentucky and operating from its Brooks, Kentucky facility, is a specialized...